Filler
BMJ updates
Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosis
BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39234.488356.DE (Published 05 July 2007) Cite this as: BMJ 2007;335:36
This article has a correction. Please see:
Abstract
Research question Is once yearly intravenous zoledronic acid an effective treatment for postmenopausal osteoporosis?
Answer Yes. Yearly treatment prevents fractures and increases bone mineral density compared with a placebo.
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.